There is currently no approved pharmacy or prescription pathway for retatrutide anywhere in the world, so all access remains strictly research use only
This drug is both a receptor agonist and a glucagon receptor agonist, so it affects the metabolic pathways that take care of body weight and how hungry you feel
GLP-1 stimulates type 3 iodothyronine deiodinase (D3) expression through the GLP-1 receptor, and the regulation of intracellular (T3) concentration by D3 may be involved in the stimulation of insulin secretion by GLP-1 (75)
By using low, consistent doses, it may help boost energy, improve mood and focus, support cardiovascular and metabolic health, reduce inflammation, and enhance cellular functionall while minimizing the side effects often associated with higher-dose GLP-1 protocols
Figure 26: Photograph of Professor Jens Holst with Dr Karen Thorne, a member of his laboratory, carrying out an experiment with a perfused pig pancreas in the 1990s, credit: Holst
At BODYWELLE, Dr